Catalyst

Slingshot members are tracking this event:

Pfizer (PFE) Presents Phase 3 S-TRAC Results Evaluating Sutent (sunitinib) in Patients with Renal Cell Carcinoma

Source Link:
http://www.pfizer.com/news/press-release/press-release-detail/first_positive_phase_3_results_in_adjuvant_setting_for_renal_cell_carcinoma_show_sutent_sunitinib_extended_disease_free_survival_after_surgical_removal

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PFE
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Oct 10, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, S-trac, Sutent, Sunitinib, Renal Cell Carcinoma, European Society For Medical Oncology
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.